Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Polypeptide Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Polypeptide Drugmarket, defines the market attractiveness level of Polypeptide Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Polypeptide Drug industry, describes the types of Polypeptide Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Polypeptide Drug market and the development prospects and opportunities of Polypeptide Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Polypeptide Drug market in Chapter 13.
By Player:
Sanofi
Asahi Kasei
Ipsen PHarma Biotech
Roche
AstraZeneca
Ferring Pharmaceuticals
Novartis
Takeda
Merck Serono
Lilly
SciClone Pharmaceuticals
By Type:
Injection
Nasal administration
Lung administration
Oral administration
Transdermal administration
By End-User:
Immunity Regulating Medicine (Allergy Infection and Immune)
Digestive System Drugs (Gastrointestinal Type)
Bone and Connective Tissue Types (Thyroid hormones Drug)
Gynecologic or Obstetric Drug
Tumor Drug
Urinary System Drug
Metabolic Drug (Insulin and Other Hypoglycemic Agents)
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Polypeptide Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Polypeptide Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Polypeptide Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Polypeptide Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Polypeptide Drug Market Analysis and Outlook to 2022
-
7.1 Global Polypeptide Drug Consumption (2017-2022)
-
7.2 United States Polypeptide Drug Consumption (2017-2022)
-
7.3 Europe Polypeptide Drug Consumption (2017-2022)
-
7.4 China Polypeptide Drug Consumption (2017-2022)
-
7.5 Japan Polypeptide Drug Consumption (2017-2022)
-
7.6 India Polypeptide Drug Consumption (2017-2022)
-
7.7 South Korea Polypeptide Drug Consumption (2017-2022)
8 Region and Country-wise Polypeptide Drug Market Analysis and Outlook to 2028
-
8.1 Global Polypeptide Drug Consumption Forecast (2022-2028)
-
8.2 United States Polypeptide Drug Consumption Forecast (2022-2028)
-
8.3 Europe Polypeptide Drug Consumption Forecast (2022-2028)
-
8.4 China Polypeptide Drug Consumption Forecast (2022-2028)
-
8.5 Japan Polypeptide Drug Consumption Forecast (2022-2028)
-
8.6 India Polypeptide Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Polypeptide Drug Consumption Forecast (2022-2028)
9 Global Polypeptide Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Polypeptide Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Injection Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Nasal administration Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Lung administration Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Oral administration Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Transdermal administration Consumption and Growth Rate (2017-2022)
-
9.2 Global Polypeptide Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Immunity Regulating Medicine (Allergy Infection and Immune) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Digestive System Drugs (Gastrointestinal Type) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Bone and Connective Tissue Types (Thyroid hormones Drug) Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Gynecologic or Obstetric Drug Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Tumor Drug Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Urinary System Drug Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Metabolic Drug (Insulin and Other Hypoglycemic Agents) Consumption and Growth Rate (2017-2022)
10 Global Polypeptide Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Polypeptide Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Nasal administration Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Lung administration Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Oral administration Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Transdermal administration Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Polypeptide Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Immunity Regulating Medicine (Allergy Infection and Immune) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Digestive System Drugs (Gastrointestinal Type) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Bone and Connective Tissue Types (Thyroid hormones Drug) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Gynecologic or Obstetric Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Urinary System Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Metabolic Drug (Insulin and Other Hypoglycemic Agents) Consumption Forecast and Growth Rate (2022-2028)
11 Global Polypeptide Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Polypeptide Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Polypeptide Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Polypeptide Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Polypeptide Drug Market Competitive Analysis
-
14.1 Sanofi
-
14.1.1 Sanofi Company Details
-
14.1.2 Sanofi Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Polypeptide Drug Product and Service
-
14.2 Asahi Kasei
-
14.2.1 Asahi Kasei Company Details
-
14.2.2 Asahi Kasei Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Asahi Kasei Polypeptide Drug Product and Service
-
14.3 Ipsen PHarma Biotech
-
14.3.1 Ipsen PHarma Biotech Company Details
-
14.3.2 Ipsen PHarma Biotech Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Ipsen PHarma Biotech Polypeptide Drug Product and Service
-
14.4 Roche
-
14.4.1 Roche Company Details
-
14.4.2 Roche Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Roche Polypeptide Drug Product and Service
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Details
-
14.5.2 AstraZeneca Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Polypeptide Drug Product and Service
-
14.6 Ferring Pharmaceuticals
-
14.6.1 Ferring Pharmaceuticals Company Details
-
14.6.2 Ferring Pharmaceuticals Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Ferring Pharmaceuticals Polypeptide Drug Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis Polypeptide Drug Product and Service
-
14.8 Takeda
-
14.8.1 Takeda Company Details
-
14.8.2 Takeda Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Takeda Polypeptide Drug Product and Service
-
14.9 Merck Serono
-
14.9.1 Merck Serono Company Details
-
14.9.2 Merck Serono Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Merck Serono Polypeptide Drug Product and Service
-
14.10 Lilly
-
14.10.1 Lilly Company Details
-
14.10.2 Lilly Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Lilly Polypeptide Drug Product and Service
-
14.11 SciClone Pharmaceuticals
-
14.11.1 SciClone Pharmaceuticals Company Details
-
14.11.2 SciClone Pharmaceuticals Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 SciClone Pharmaceuticals Polypeptide Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Polypeptide Drug
-
Figure Polypeptide Drug Picture
-
Table Global Polypeptide Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Polypeptide Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Polypeptide Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Polypeptide Drug Consumption by Country (2017-2022)
-
Figure United States Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure China Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure India Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Polypeptide Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Nasal administration Consumption and Growth Rate (2017-2022)
-
Figure Global Lung administration Consumption and Growth Rate (2017-2022)
-
Figure Global Oral administration Consumption and Growth Rate (2017-2022)
-
Figure Global Transdermal administration Consumption and Growth Rate (2017-2022)
-
Figure Global Immunity Regulating Medicine (Allergy Infection and Immune) Consumption and Growth Rate (2017-2022)
-
Figure Global Digestive System Drugs (Gastrointestinal Type) Consumption and Growth Rate (2017-2022)
-
Figure Global Bone and Connective Tissue Types (Thyroid hormones Drug) Consumption and Growth Rate (2017-2022)
-
Figure Global Gynecologic or Obstetric Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Urinary System Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Metabolic Drug (Insulin and Other Hypoglycemic Agents) Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nasal administration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung administration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral administration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Transdermal administration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunity Regulating Medicine (Allergy Infection and Immune) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Digestive System Drugs (Gastrointestinal Type) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bone and Connective Tissue Types (Thyroid hormones Drug) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gynecologic or Obstetric Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urinary System Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metabolic Drug (Insulin and Other Hypoglycemic Agents) Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Polypeptide Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Polypeptide Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Polypeptide Drug Product and Service
-
Table Asahi Kasei (Foundation Year, Company Profile and etc.)
-
Table Asahi Kasei Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Asahi Kasei Polypeptide Drug Product and Service
-
Table Ipsen PHarma Biotech (Foundation Year, Company Profile and etc.)
-
Table Ipsen PHarma Biotech Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen PHarma Biotech Polypeptide Drug Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Polypeptide Drug Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Polypeptide Drug Product and Service
-
Table Ferring Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Ferring Pharmaceuticals Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ferring Pharmaceuticals Polypeptide Drug Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Polypeptide Drug Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Polypeptide Drug Product and Service
-
Table Merck Serono (Foundation Year, Company Profile and etc.)
-
Table Merck Serono Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Serono Polypeptide Drug Product and Service
-
Table Lilly (Foundation Year, Company Profile and etc.)
-
Table Lilly Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lilly Polypeptide Drug Product and Service
-
Table SciClone Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table SciClone Pharmaceuticals Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table SciClone Pharmaceuticals Polypeptide Drug Product and Service
-
